13F

Stock

Cadrenal Therapeutics, Inc.

CVKD · held by 20 managers

Reported value

$452.1K

Holders

20

+4 new · −5 exited

Holders’ est. mark

−$51K

Price effect on 15 books still in the name

Largest holder

$231.4K

VANGUARD CAPITAL MANAGEMENT LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
VANGUARD CAPITAL MANAGEMENT LLC45.2K$231.4KHeld
GEODE CAPITAL MANAGEMENT, LLC21.6K$110.7K−$24.1KAdded$12.2K
VANGUARD FIDUCIARY TRUST CO8.31K$42.6KHeld
JPMORGAN CHASE & CO7.5K$31.9K−$19KCut−$19K
BlackRock, Inc.5.5K$28.1K−$5.85KAdded$4.26K
Tower Research Capital LLC (TRC)393$2.01K−$653Cut−$1.59K
OSAIC HOLDINGS, INC.300$1.54K−$498Cut−$1.85K
Destiny Wealth Partners, LLC200$1.02KNew
Rockefeller Capital Management L.P.150$768−$249Cut−$1.27K
MORGAN STANLEY100$512−$166Cut−$6.81K
HARBOUR INVESTMENTS, INC.100$512−$166Cut−$166
WELLS FARGO & COMPANY/MN99$507−$164Cut−$164
Archer Investment Corp35$179−$58Cut−$58
IFP Advisors, Inc30$154−$49Cut−$49
Farther Finance Advisors, LLC25$123−$47Cut−$47
CALDWELL SUTTER CAPITAL, INC.5$26−$8Cut−$8
UBS Group AG3$15−$5Cut−$7.06K
Cygnus Capital Advisors, LLC1.49K$8New
CITIGROUP INC1$5New
CURIO WEALTH, LLC1$5−$2Cut−$2

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.